i was checking out the authors. They seem to be experts in the field.
https://www.researchgate.net/profile/Margaret-Smith-36 https://sciprofiles.com/user/publications/2288748
https://scholar.google.com/citations?user=fzBb8KEAAAAJ&hl=en
J.M. (James Melrose) has received consultancy fees from Arthropharm Pharmaceuticals Pty Ltd. M.M.S (Margaret M Smith). is a clinical research director at Arthropharm Pharmaceuticals Pty Ltd.
But tThey are associated wit Arthropharm Pty Ltd. This company bottles Cartrophen and Elmiron. in Australia and the have a Canadian arm.
https://www.arthropharm.com.au/about
https://www.tga.gov.au/resources/artg/48446
https://apvma.gov.au/node/12326#A
Arthropharm Pty LtdAddress:105–113 Bronte RoadBondi Junction NSW 2022Licence No: 1107Product types:Category 1: Sterile products for injectionStep(s) of manufacture:Quality Assurance (QA) of raw materials, formulation including blending, aseptic filling, packaging, secondary packaging, labelling, sterilisation (heat, filtration), analysis and testing (physical, chemical, endotoxin, microbiological and sterility), storage and release for supply.Date of issue:24/10/2017
According to their website they are:
"Pioneers in the scientific research and clinical application of the large complex molecule PPS
Arthropharm Australia is a world leader in the research and development of sulfated polysaccharides"
They want people to contact them about Clinical trials for treatment of human arthritis
https://www.arthropharm.com.au/research
The TGA gave them a slap on the wrist for "failure to provide information on a contact person responsible for medicine safety"
https://www.tga.gov.au/news/media-releases/arthropharm-pty-ltd-fined-13320-alleged-breaches-therapeutic-goods-legislation
Arthropharm seems to be a wholesale distributor. So why are their associated scientists writing papers on PPS? and the website is talking about clinical trials?
They have some patents as well...
https://goodip.io/iq/assignee/arthropharm-pty-ltd
Arthropharm own the patent for mammalian treatment: https://patents.google.com/patent/US6593310B1/en
Paul Rennie and Ravi Krishnan's abandonded patent references the Arthopharm patent
https://patents.google.com/patent/AU2018309566A1/ko
Peter Ghosh is on this one
https://patents.google.com/patent/US5145841A/en?assignee=Arthropharm+Pty+Ltd&oq=Arthropharm+Pty+Ltd
It looks like the genesis of paradigm came from Arthropharm. I wonder if there are any competing claims possible down the track.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-3620
-
-
- There are more pages in this discussion • 809 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M |
Open | High | Low | Value | Volume |
19.5¢ | 21.0¢ | 19.5¢ | $80.51K | 398.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 112938 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 4396 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 112938 | 0.200 |
8 | 185493 | 0.195 |
18 | 390135 | 0.190 |
4 | 68313 | 0.185 |
9 | 149295 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 4396 | 1 |
0.215 | 19607 | 1 |
0.220 | 50066 | 5 |
0.225 | 68604 | 2 |
0.230 | 15000 | 3 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |